MedPage Today November 14, 2025
At issue: will the new flat fee hurt patient access?
Virtually everyone in the wound care space agreed that the existing payment structure for high-price skin substitutes was flawed, but stakeholders disagreed on the best way to fix it.
Late last month, CMS released the annual physician fee schedule, which radically changed how skin substitutes are reimbursed in an effort to root out rampant profiteering in the industry.
In conversations with MedPage Today, experts and stakeholders clashed over whether the new payment limits are adequate and whether the approach will ultimately hurt or harm patients.
Under the new rule, instead of paying for skin substitutes as it does biologics — using an average sales price plus 6% — CMS re-categorized...
Today's Sponsors
Today's Sponsor